Rockwell Medical

Q3 2025 -9.22%Q2 2025 -1.96%Q1 2025 -6.42%Q4 2024 -20.45%Q3 2024 -43.44%Q2 2024 +22.60%Q1 2024 +0.59%Q4 2023 +3.64%Q3 2023 +12.18%Q2 2023 -7.38%Q1 2023 -4.49%Q4 2022 +14.56%Q3 2022 +28.16%Q2 2022 +11.96%Q1 2022 +2.97%Q4 2021 -13.64%Q3 2021 -7.69%Q2 2021 -6.15%Q1 2021 -2.17%Q4 2020 +4.50%Q3 2020 +1.12%Q2 2020 +4.19%Q1 2020 -4.72%Q4 2019 -42.71%Q3 2019 +5.38%Q2 2019 -5.65%Q1 2019 -7.54%Q4 2018 +2.96%Q3 2018 +8.91%Q2 2018 -15.51%Q1 2018 -2.45%Q4 2017 -17.46%Q3 2017 +9.63%Q2 2017 -4.21%Q1 2017 -1.23%Q4 2016 +10.02%Q3 2016 -20.46%Q2 2016 -8.94%Q1 2016 +19.69%Q4 2015 -36.77%Q3 2015 -10.54%Q2 2015 +11.51%Q1 2015 +12.94%Q4 2014 -6.63%Q3 2014 +5.69%Q2 2014 +0.10%Q1 2014 -8.47%Q4 2013 +3.06%Q3 2013 -0.77%Q2 2013 +0.59%Q1 2013 -7.60%Q4 2012 -19.91%Q3 2012 -3.33%Q2 2012 -6.38%Q1 2011 -0.23%Q1 2012 +0.95%Q4 2011 -4.37%Q3 2010 -9.26%Q3 2011 -9.26%Q2 2010 -0.11%Q2 2011 -0.11%Q4 2010 -1.44%Q1 2010 +3.35%

Nov 14, 2022

•

Sep 30, 2022

Rockwell Medical Q3 2022 Earnings Report

Announced third quarter 2022 financial and operational results and provided business strategy update.

Key Takeaways

Rockwell Medical reported revenue of $18.7 million for the third quarter of 2022, the highest quarterly revenue to date, and reduced cash used in operating activities by 81% compared to the previous quarter. The company is restructuring its business to focus on revenue-generating businesses and expects to achieve profitability in 2024.

Revenue for Q3 2022 was $18.7 million, the highest quarterly revenue to date.

Cash used in operating activities decreased by 81% to $1.1 million for Q3 2022.

Long-term debt was reduced from $15 million to $10 million.

The company expects to achieve profitability in 2024.

Previous year: -$0.88

-54.5%